Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo
Table 3
Combination index (CI) value of the combination therapy of AZD6244 and MK2206 at the ratio of 5∶1.